These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 8799639)
1. Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patients. Tack CJ; Wetzels JF Diabetes Care; 1996 Jul; 19(7):775-6. PubMed ID: 8799639 [TBL] [Abstract][Full Text] [Related]
2. Drug-induced haemolysis and fast haemoglobin A1 in diabetes mellitus. Kesson CM; Whitelaw JW; Ireland JT Br Med J; 1979 Oct; 2(6197):1037-8. PubMed ID: 519273 [No Abstract] [Full Text] [Related]
3. Hemolytic anemia in patients receiving sulfasalazine. Goodacre RL; Ali MA; Vanderlinden B; Hamilton JD; Castelli M; Seaton T Digestion; 1978; 17(6):503-8. PubMed ID: 30666 [TBL] [Abstract][Full Text] [Related]
4. Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. Kahn BB; Rosen AS; Bak JF; Andersen PH; Damsbo P; Lund S; Pedersen O J Clin Endocrinol Metab; 1992 May; 74(5):1101-9. PubMed ID: 1569156 [TBL] [Abstract][Full Text] [Related]
5. [Measure of glycosylated hemoglobin A1c: its value in the control of juvenile insulin-dependent diabetes (author's transl)]. Jos J; Wajcman H; Labie D; Leroy D; Bougnères P Nouv Presse Med; 1980 Jul 12-26; 9(30):2053-6. PubMed ID: 6995937 [TBL] [Abstract][Full Text] [Related]
6. Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Goldstein DE; Walker B; Rawlings SS; Hess RL; England JD; Peth SB; Hewett JE Diabetes Care; 1980; 3(4):503-7. PubMed ID: 7006943 [TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine-induced mononucleosis-like-illness and haemolysis. Sahm J; de Groot K; Schreiber J Scand J Rheumatol; 2021 Jan; 50(1):83-84. PubMed ID: 32468961 [No Abstract] [Full Text] [Related]
8. Comparison of energy metabolism in insulin-dependent and non-insulin-dependent diabetes mellitus. Takata K; Chiba N; Tawara M; Yamanaka H; Syuto E; Miyamoto K; Yokota I; Matsuda J; Kuroda Y; Takeda E J Med Invest; 1997 Aug; 44(1-2):67-71. PubMed ID: 9395720 [TBL] [Abstract][Full Text] [Related]
9. [Hemolysis, formation of Heinz bodies and of methemoglobin under therapy with Azulfidine (author's transl)]. Kater F Med Klin; 1974 Mar; 69(11):466-8. PubMed ID: 4151648 [No Abstract] [Full Text] [Related]
10. [Selected parameters of blood coagulation and fibrinolysis and their relationship to the level of diabetes control in patients with insulin-dependent diabetes mellitus]. Majkowska L; Mamos E; Fuchs H; Pynka S; Jastrzebska M; Krzyzanowska B; Czekalski S Pol Arch Med Wewn; 1994 Aug; 92(2):147-53. PubMed ID: 7800583 [TBL] [Abstract][Full Text] [Related]
11. [Glycosylated hemoglobin HbA1c as an indicator of metabolic compensation in children with diabetes mellitus]. Michalková D; Carský J; Bircák J; Kolár J; Baciaková L; Vitková M; Zmeková E Cesk Pediatr; 1981 May; 36(5):243-7. PubMed ID: 7261146 [No Abstract] [Full Text] [Related]
12. [HbA1c: need of its dosage in diabetics (author's transl)]. Clarke J; Passa P; Canivet J Nouv Presse Med; 1979 Feb; 8(7):513-7. PubMed ID: 461162 [TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis. Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192 [TBL] [Abstract][Full Text] [Related]
14. Hemolysis during salicylazosulfapyridine therapy. van Hees PA; van Elferen LW; van Rossum JM; van Tongeren JH Am J Gastroenterol; 1978 Nov; 70(5):501-5. PubMed ID: 33552 [TBL] [Abstract][Full Text] [Related]
15. The use of glycosylated haemoglobin measurements in the control of the diabetic patient. Distiller LA; Zail SS S Afr Med J; 1979 Mar; 55(9):335-7. PubMed ID: 441895 [TBL] [Abstract][Full Text] [Related]
16. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906 [TBL] [Abstract][Full Text] [Related]
17. [The HbA1c-determination with the aid of isoelectrofocusing method in the out patient control of juvenile diabetics (author's transl)]. Marg W; Gunschera H; Henke-Wolter J Klin Padiatr; 1982 Jan; 194(1):56-9. PubMed ID: 7062689 [TBL] [Abstract][Full Text] [Related]
18. Assessment of membrane stabilizing activity from honey. An in-vitro approach. Manukumar HM; Umesha S Acta Sci Pol Technol Aliment; 2015; 14(1):85-90. PubMed ID: 28068024 [TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein(a) concentrations in type I diabetes mellitus]. Figueroa AC; Gil RL; Pedragós AC; González GC; Marqués RB; Díaz JA; Llanos JO; Pérez AP Rev Clin Esp; 1996 Feb; 196(2):87-91. PubMed ID: 8685494 [TBL] [Abstract][Full Text] [Related]
20. In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c. Pant V; Shrestha A; Pyakurel D; Gautam K; Pradhan S EJIFCC; 2021 Oct; 32(3):377-384. PubMed ID: 34819826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]